Startups & growth Analysis
Editpep develops a nonviral way to deliver CRISPR for brain therapies
Editpep is developing a nonviral way to deliver CRISPR machinery, with brain therapies as its first focus and licensing as a possible commercial route.
E
MoneyMakers coverage
Editpep: news & coverage
Page 1 of 1 · 1 report
Editpep develops nonviral CRISPR delivery technology for potential therapies, initially focused on the brain.
Published reporting on Editpep. Entries describe developments as reported on their publication dates.
All reporting
